BlackRock, Inc. - 31 Mar 2025 SCHEDULE 13G/A Report for BLUEPRINT MEDICINES CORP Common Stock (BPMC)

Filing Manager
BlackRock, Inc.
Reporting Manager
BlackRock, Inc.
Security
BLUEPRINT MEDICINES CORP Common Stock
Symbol
BPMC
Shares outstanding
63,634,038 shares
Disclosed Ownership
5,090,723 shares
Ownership
8%
Form type
SCHEDULE 13G/A
Filing time
23 Apr 2025, 20:19:37 UTC
Date of event
31 Mar 2025
SEC
View on sec.gov

Key filing fact

BlackRock, Inc. disclosed 8% ownership in BLUEPRINT MEDICINES CORP Common Stock (BPMC) on 31 Mar 2025.

Key facts

  • BlackRock, Inc. filed SCHEDULE 13G/A for BLUEPRINT MEDICINES CORP Common Stock (BPMC).
  • Disclosed ownership: 8%.
  • Date of event: 31 Mar 2025.

Change

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 23 Apr 2025, 20:19.

Research use

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting persons

Reporting managers (1)

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BlackRock, Inc. 8% 5,090,723 5,018,191 0 Spencer Fleming Managing Director
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .